What's New

News

Follow AFTD on TikTok and contribute your own videos!

Follow AFTD on TikTok and Contribute Your Own Stories 

AFTD has launched a new social media account on TikTok to help spread awareness of FTD online…

Read More >
FDA Announcement on ALS Drug

FDA Announcement on ALS Drug Reflects Growing Hope for Treatments

The FDA’s recent approval of a new drug to treat ALS signals important and promising developments for…

Read More >
AFTD is please to announce that social media influencer Nicole Petrie as a new brand ambassador for the organization

AFTD Pleased to Announce New Brand Ambassador Nicole Petrie

ADTD is pleased to announce an official partnership with Nicole Petrie, a social media influencer and AFTD…

Read More >
AFTD ambassador Deb Scharper highlights how difficult getting an FTD diagnosis can be

AFTD Ambassador Highlights Difficulties in Getting an FTD Diagnosis 

AFTD Ambassador Deb Scharper shared the difficulties that she faced trying to get an accurate FTD diagnosis…

Read More >

How to Support AFTD’s Mission through Your Workplace 

AFTD’s volunteers and donors are essential to advancing our mission. Each contribution of time and funds provides…

Read More >
Bob Powers performed his one person show "Chasing Rainbows" in Portland in honor of his late husband, Donald, and to raise money for AFTD's mission

“Chasing Rainbows” Play Debuts in Portland, Raises Funds for AFTD’s Mission

Stage actor Bob Powers debuted his one-person play Chasing Rainbows: A Story of Love, Loss, and Finding…

Read More >
Dr. Bruce Miller Discusses bvFTD and Differences Between FTD Variants in Podcast Appearance

Dr. Bruce Miller Discusses bvFTD and Differences Between FTD Variants in Podcast Appearance

 Bruce Miller, MD, discussed behavioral variant frontotemporal degeneration as well as the differences between different FTD variants…

Read More >
Communications Bridge allows people with PPA to receive speech-language threapy in a telehealth setting

In-Progress Clinical Trial Evaluating Speech Therapy for People with PPA

The Communications Bridge 2 clinical trial is currently evaluating whether a specially developed speech therapy regimen could…

Read More >
Passage Bio Issues First Dose in FTD Gene Therapy Trial

Passage Bio Issues First Dose in FTD Gene Therapy Trial

Passage Bio, a company that specializes in developing genetic therapies, administered the first dose in a clinical…

Read More >
Newspaper Editor Writes About Wife’s PPA Journey

Newspaper Editor Writes About Wife’s PPA Journey

Earlier this year, Blake Ovard, an AFTD volunteer and editor for the Hobbs News-Sun newspaper in New…

Read More >